Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Long Chai Jiang Xue Fang is a Traditional Chinese Medicine (TCM) herbal formula primarily developed for the treatment of H-type hypertension, a condition characterized by high blood pressure combined with elevated plasma homocysteine levels. The formula is typically indicated for patients presenting with the TCM pattern of "liver-fire hyperactivity." It is derived from classical TCM prescriptions, such as *Chaihu Jia Longgu Muli Tang*, and aims to clear liver fire, calm the liver, and regulate blood pressure. Clinical research conducted in China suggests that the formula can effectively reduce both systolic and diastolic blood pressure while simultaneously lowering serum homocysteine levels, potentially reducing the risk of cardiovascular and cerebrovascular complications associated with H-type hypertension. It is usually administered orally as a decoction or in granule form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Long Chai Jiang Xue Fang.